Convertibles used to be a big deal. Here are 10 from the 1990s golden age that nobody seems to talk about much these days ...
Prothena (NASDAQ:PRTA) used its fourth-quarter and full-year 2025 results call to highlight partner-driven clinical momentum, updates from its wholly owned preclinical portfolio, and a sharper cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results